Crosswalk: CMS-64.21U

Crosswalk for the implementation of the Revisions of (CMS-64.21U) VALUE BASED PURCHASING DRUG REBATE OFFSET in MBES/CBES on the current CMS 64.21U Form series, starting Quarter beginning 10/01/2022 Type of Change Rationale for the Change
64.21U Expenditure Form series: CMS is adding the new Line item 8A7 VALUE BASED PURCHASING DRUG REBATE OFFSET	A line that allows for Total Computable (A) entry for Drug Rebate Offset - Value Based Purchasing	Implementation of the final rule regarding the reporting of Drug Rebate Offset amounts as a result of the VBP legislation will require a new line item. LINE 8A7, DRUG REBATE OFFSET – VALUE BASED PURCHASING, will be added to the Form CMS-64.21U MCHIP series of forms. The line will be available for entry beginning October 1, 2022, for all states and territories that have drug rebates that are related to prescribed drugs that were purchased under the VBP guidelines. The line is necessary for accurate reporting, transparency, and oversight of states’ and territories’ Medicaid and MCHP drug rebates returned by states and territories. Total Computable will be enterable for Indian Health Services, Family Planning, and for Optional Breast and Cervical Cancer which is at the Enhanced FMAP rate.